瑞士早发性结直肠癌发病率上升而老年人群下降:1980-2021年全国人群研究
该研究基于瑞士全国癌症登记数据,纳入1980-2021年确诊的96'410例结直肠腺癌患者,其中5'928例(6.1%)年龄低于50岁。早发性结直肠癌发病率持续上升(男性APC +0.46%,女性+0.49%),且诊断时IV期比例更高(27.7% vs 老年组22.1%和19.4%),而老年人群发病率在2000年代中期后下降。
要点
- 早发性结直肠癌发病率持续上升,男性APC +0.46%,女性+0.49%。
- 早发性患者IV期比例达27.7%,高于50-74岁(22.1%)和≥75岁(19.4%)。
- 老年人群结直肠癌发病率在2000年代中期后下降。
核心结论
- 瑞士早发性结直肠癌发病率持续上升,诊断时分期较晚,生存改善不均匀,需调整预防、意识和筛查策略。
研究设计与样本
- 全国性人群为基础的研究,纳入1980-2021年确诊的20岁及以上首诊结直肠腺癌患者,数据来自国家癌症登记机构提供的国家癌症数据集。
主要发现
- 共纳入96'410例患者,其中5'928例(6.1%)年龄低于50岁。
- 早发性结直肠癌中直肠癌占31.8%,而≥75岁组为22.9%;近端结肠癌在早发性组占30.5%,≥75岁组占42.7%。
- 2010-2021年间,早发性结直肠癌中UICC IV期占27.7%,50-74岁组为22.1%,≥75岁组为19.4%。
- 早发性结直肠癌发病率男性APC +0.46%(95% CI 0.17-0.76),女性+0.49%(95% CI 0.17-0.81),由直肠癌(两性)和年轻女性近端结肠癌驱动。
- 老年人群发病率在2000年代中期后下降;年轻男性5年净生存率在2010年达峰值76.9%,年轻女性在2007年达78.2%。
临床怎么用
- 临床应关注年轻成人结直肠癌风险,对相关症状保持警惕,促进早期诊断和适当筛查。
局限性
- 分期分布仅分析2010-2021年 harmonized TNM 数据可得的时段。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The incidence of colorectal cancer in adults younger than 50 years has increased, but the trends of incidence in Switzerland has not been yet described. We assessed long-term incidence, stage distribution, and survival of early-onset colorectal cancer (EOCRC) in Switzerland. MATERIALS AND METHODS: We conducted a nationwide, population-based study including all patients aged 20 years or older who were diagnosed with a first colorectal adenocarcinoma between 1980 and 2021, based on data from the National Cancer Dataset provided from the National Agency for Cancer Registration (NACR). Age-standardized incidence rates per 100'000 person-years were calculated using the 1976 European Standard Population. Temporal trends were assessed using joinpoint regression, expressed as annual percent change (APC). Stage distribution was analysed for 2010-21, when harmonized TNM data were available. Five-year net survival was estimated using the Pohar-Perme estimator. RESULTS: Among 96'410 patients, 5'928 (6.1%) were below 50 years old. Rectal cancers comprised 31.8% of EOCRC, versus 22.9% in those aged ≥ 75 years, whereas proximal colon cancers were less common (30.5% vs 42.7%, respectively). From 2010 to 2021, 27.7% of EOCRC were UICC stage IV, compared with 22.1% at ages 50-74 and 19.4% at ≥ 75. EOCRC incidence rose steadily (men: APC +0.46% [95% CI 0.17-0.76]; women: +0.49% [0.17-0.81]), driven by rectal cancers in both sexes and proximal colon cancers in young women. In contrast, incidence declined in older adults after the mid-2000s. Five-year net survival improved and reached a peak of 76.9% in 2010 for young men and 78.2% in 2007 for young women. DISCUSSION: EOCRC incidence in Switzerland has risen continuously, with advanced stage at diagnosis and heterogeneous survival gains, underscoring the need for adapted prevention, awareness, and screening strategies.
引用
- Fournier E, Schaffar R, Staehelin K, et al. Rising early-onset colorectal cancer in Switzerland despite declining incidence in older adults: A nationwide population-based study, 1980-2021. Eur J Cancer. 2026. PMID: 41946179. doi:10.1016/j.ejca.2026.116707
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。